Three Fish & Richardson Principals Honored in 2023 LMG Life Sciences Awards

Three Fish & Richardson principals were recognized as among the best in their practice areas in this year's LMG Life Sciences Awards.

  • Corrin Drakulich: Winner, General Patent Litigator of the Year — South
  • Caleb Bates: Winner, U.S. Rising Star — Intellectual Property
  • J. Kevin Gray: Winner, Patent Strategy Attorney of the Year — South

Corrin Drakulich is a first-chair trial lawyer for complex patent and intellectual property disputes and an elected member of the firm’s Management Committee. As Fish’s litigation practice group leader, Drakulich serves as the global head of litigation for the firm’s nearly 200-lawyer Litigation Practice Group. She focuses her practice on complex IP cases and has particular experience in patent litigation involving pharmaceuticals, medical devices, and biotechnology.

Caleb Bates is a trusted advisor and partner with emerging and established companies, developing patent portfolios that support their growth strategies by protecting their valuable IP and maximizing loss of exclusivity. He manages the worldwide prosecution strategy for several pre-clinical and clinical-stage biopharmaceutical companies, including portfolios with hundreds of filings across more than 45 jurisdictions.

J. Kevin Gray’s practice encompasses all aspects of IP law, with an emphasis on complex transactions and licensing of IP and other proprietary rights. He is the national chair of Fish’s IP licensing, transactions, and agreements practice. Gray routinely handles more than 100 types of IP licensing and technology agreements for organizations ranging from startups to technology transfer offices to multinational corporations.

The world's most innovative life sciences companies, academic institutions, and research organizations trust Fish's Life Sciences Group — with its more than 115 attorneys and technical specialists with biology, chemistry, or genetic engineering degrees, including over 50 attorneys with Ph.D.s — to handle their most important and technically sophisticated work. Fish's litigation practice is known for its ability to handle massive, high-profile patent disputes requiring extensive global litigation coordination, and the firm is a leader in Hatch-Waxman litigation for branded pharmaceutical companies.